Press releases

Here you can find corporate releases on topics related to governance, investments, and important announcements.

Read more

Investors

Nasdaq:

CRMD

$ 4.98 Last update: 06/02/2023 12:05:41 am ET Time Read more

About CRBSI

Learn more about Catheter-related blood stream infections (CRBSIs) and how they affect hemodialysis central venous catheter (HD-CVC) patients.

Read more
WHY CORMEDIX

We relentlessly pursue therapeutic options to reduce and treat infectious and inflammatory disease

About us
PRESS RELEASES

Review corporate releases related to governance,
investor news, and other important announcements.

May 30, 2023

CORMEDIX INC. TO PRESENT AT THE JEFFERIES HEALTHCARE CONFERENCE
May 16, 2023

CORMEDIX INC. ANNOUNCES RESUBMISSION OF NEW DRUG APPLICATION FOR DEFENCATH
May 08, 2023

CORMEDIX INC. TO REPORT FIRST QUARTER 2023 FINANCIAL RESULTS AND PROVIDE A CORPORATE UPDATE ON MAY 15, 2023
May 03, 2023

CORMEDIX INC. TO PARTICIPATE IN TWO UPCOMING INVESTOR CONFERENCES
May 01, 2023

CORMEDIX INC. ANNOUNCES NOTICE OF ALLOWANCE FOR U.S. PATENT APPLICATION COVERING LEAD PRODUCT DEFENCATH
See all